+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 75Years
All Genders
ID06657248

Evaluating Midterm Safety and Performance of the Unicompartmental Univation XF Pro Knee Implant in a Prospective Multicenter Observational Study

Led by Aesculap AG · Updated on 2026-10-16

150

Participants Needed

4

Research Sites

261 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a prospective, observational follow-up study to evaluate the mid-term safety and performance of the unicompartmental univation XF Pro knee implant. This study involves 150 patients across four centers in Germany and focuses on patients requiring primary medial unicompartmental knee arthroplasty. The implant is used according to its authorized instructions in routine clinical practice. Participants receive the univation XF Pro implant as part of their standard knee replacement surgery. Clinical data are collected during routine care and documented electronically. The study aims to gather information on implant safety and function over time, assessing outcomes such as implant survival and quality of life during follow-up periods extending up to five years post-surgery. During the study, participants undergo various assessments including patient-reported functional outcomes, quality of life surveys, and radiological evaluations at discharge and at multiple intervals up to five years after the operation. Researchers monitor adverse events and radiological complications throughout the follow-up to better understand the implants mid-term performance.

CONDITIONS

Brief Title

Clinical Performance and Safety of the Unicompartmental Univation® XF Pro Implant

Research Team

P

Petra Wain

S

Stefan Maenz, Dr.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here